Cap for an injection device
Latest Sanofi-Aventis Deutschland GMBH Patents:
- Drive mechanisms suitable for use in drug delivery devices
- USE OF SACCHAROMYCES CEREVISIAE ERG4 MUTANTS FOR EXPRESSING MAMMALIAN GLUCOSE TRANSPORTERS
- Heterocyclically substituted 7-amino-4-quinolone-3-carboxylic acid derivatives, process for their preparation and their use as medicaments
- Processes for the preparation of (R)-?-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol
- THE USE OF SACCHAROMYCES CEREVISIAE ERG4 MUTANTS FOR EXPRESSING MAMMALIAN GLUCOSE TRANSPORTER
Description
Claims
The ornamental design for a cap for an injection device as shown and described.
Referenced Cited
U.S. Patent Documents
Other references
| 6575939 | June 10, 2003 | Brunel |
| D545364 | June 26, 2007 | Temovits |
| D650857 | December 20, 2011 | Lira-Nunez et al. |
| D697205 | January 7, 2014 | Schneider et al. |
| D708317 | July 1, 2014 | Schneider et al. |
| D731051 | June 2, 2015 | Olson et al. |
| D732161 | June 16, 2015 | Ohashi |
| D757255 | May 24, 2016 | Wohlfahrt et al. |
| D758567 | June 7, 2016 | Wohlfahrt et al. |
| D758569 | June 7, 2016 | Wohlfahrt et al. |
| D773648 | December 6, 2016 | Wohlfahrt et al. |
| D789528 | June 13, 2017 | Wohlfahrt et al. |
| D793547 | August 1, 2017 | Burkett et al. |
| D861859 | October 1, 2019 | Rapp et al. |
| D926967 | August 3, 2021 | Rogge et al. |
| D931445 | September 21, 2021 | Jones et al. |
| D934413 | October 26, 2021 | Nicholas et al. |
| D944976 | March 1, 2022 | Bainton et al. |
| D946141 | March 15, 2022 | Krulevitch et al. |
| D948715 | April 12, 2022 | Hezkiahu et al. |
| D951441 | May 10, 2022 | Murakami et al. |
| D952835 | May 24, 2022 | Van Der Beek et al. |
| D953526 | May 31, 2022 | Fournier et al. |
| D953527 | May 31, 2022 | Fournier et al. |
| D956211 | June 28, 2022 | Bourelle et al. |
| D956212 | June 28, 2022 | Petersen et al. |
| D956215 | June 28, 2022 | Krulevitch et al. |
| D985117 | May 2, 2023 | Davis |
| D985118 | May 2, 2023 | Davis |
| D985119 | May 2, 2023 | Melander |
| D988508 | June 6, 2023 | Rapp et al. |
| D1010107 | January 2, 2024 | Melander |
| D1030040 | June 4, 2024 | Kaare Soelberg |
| D1030044 | June 4, 2024 | Scott |
| D1034976 | July 9, 2024 | Schneider |
| D1038380 | August 6, 2024 | DiLuzio |
| D1042803 | September 17, 2024 | Edwald |
| D1043967 | September 24, 2024 | Rogge |
| D1071212 | April 15, 2025 | Moriwake |
| D1076078 | May 2025 | Kucklick |
| D1106445 | December 16, 2025 | Davis |
| D1118142 | March 17, 2026 | Welsh |
- SelfDose Patient-Controlled Injector https://www.westpharma.com/products/self-injection-platforms/selfdose downloaded from the internet Mar. 25, 2026 (Year: 2026).
Patent History
Patent number: D1156619
Type: Grant
Filed: Jun 5, 2023
Date of Patent: Nov 3, 2026
Assignee: Sanofi-Aventis Deutschland GMBH (Frankfurt am Main)
Inventors: Katrin Rapp (Frankfurt am Main), Oliver Greven (Frankfurt am Main), Marc Schader (Frankfurt am Main)
Primary Examiner: David G Muller
Application Number: 29/877,306
Type: Grant
Filed: Jun 5, 2023
Date of Patent: Nov 3, 2026
Assignee: Sanofi-Aventis Deutschland GMBH (Frankfurt am Main)
Inventors: Katrin Rapp (Frankfurt am Main), Oliver Greven (Frankfurt am Main), Marc Schader (Frankfurt am Main)
Primary Examiner: David G Muller
Application Number: 29/877,306
Classifications
Current U.S. Class:
Syringe, Catheter Or Needle Component (22) (D24/130)